Confusion from Profusion: Decision Making with Many Options
Confusion from Profusion: Decision Making with Many Options
批准号:
7575643
负责人:
Mikhael Shor
金额:
$14.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-01 至 2011-02-28
关键词:
AffectAgeAmericanBehavioralCharacteristicsComplementComplexConfusionControlled EnvironmentDecision MakingDemographic FactorsDeteriorationDevelopmentDrug PrescriptionsEconomicsEducational BackgroundElderlyEnvironmentEvolutionExperimental DesignsFaceFinancial compensationFoundationsFrequenciesGeneral PopulationGoalsGuidelinesHealthHealth InsuranceHealth PlanningHealthcareIndividualInvestigationLeadLifeMeasuresMedicareModelingOutcomeOutcome StudyParalysedPerformancePersonsPharmaceutical PreparationsPlayPoliciesPolicy MakerProcessProtocols documentationRecommendationRecruitment ActivityResearchResearch Project GrantsRetirementRiceRoleSeriesStructureSuggestionSurveysTestingTimeVariantVisitWorkaging populationbasedesignexperiencefield studyfinancial incentiveimprovedinformation processinginsightmeetingspaymentresearch studyretireesexsoundtheories
中文摘要
描述(由申请人提供):美国人在健康和药物保险计划中有许多选择。对于医疗保险D部分药物覆盖计划来说尤其如此。增加的选择通常与更大的可能性相关,即一个可用的选项将最好地满足个人的特定需求,但过多的选择可能会造成混乱,导致选择错误。这个项目的目的是为了更好地理解为什么个人在面对复杂的决策时经常做出糟糕的选择,并提出指导方针和选择界面设计,以提高个人的决策绩效。我们的实验方法是量化当个人被要求从一组竞争计划中选择最优计划时选择错误的频率和程度。这一决定非常类似于在药物计划中选择包括某些药物但不包括其他药物的任务,但也普遍适用于其他健康计划的选择选择。拟议的实验界面将为每个受试者提供一系列矩阵,每个矩阵显示每个选择选项(即所有可用的D部分药物计划)的属性(类似于覆盖和未覆盖的药物集)。实验对象将被要求从可选方案中选择最佳方案,并将根据其选择的准确性获得经济补偿。我们将系统地研究受试者的决策是如何受到他们所面临的复杂问题的影响的。此外,实验界面的变化将测试关于人们如何处理信息和做出复杂选择的竞争性行为理论,从而导致决策模型的发展,改进的格式可以进行测试。实验设计的核心将是仔细调查决策敏锐度作为人口因素的函数,包括教育水平、性别,尤其是年龄(初步工作表明老年人在复杂环境中表现不佳)。受试者将通过亲自访问老年人设施和电子方式从一个非常大的人口统计学多样化的在线实验经济学主题池中招募。将测量受试者池之间的差异以及薪酬金额对受试者绩效的影响。项目成果将包括向决策者提出的关于构建复杂选择以尽量减少选择错误的建议。因此,表现不佳的群体可以在医疗保险和药物覆盖方面做出更好的选择,从而改善老年人的健康状况。项目说明:该项目的目标是进一步了解人们在做出复杂决定时可能出现的错误,例如在选择医疗保健和药物覆盖计划时。这项研究将检查一般人群和表现较差的亚群体之间决策敏锐度的潜在差异,可能与教育水平、性别,尤其是年龄有关。研究结果将包括重组决策集的建议,使表现不佳的群体,特别是老年人,能够做出更好的长期选择,改善他们自己的健康结果。
英文摘要
DESCRIPTION (provided by applicant): Americans have many alternatives among health and drug coverage plans. This is particularly true for Medicare Part D drug coverage plans. Increased choice usually correlates with a greater chance that an available option will best meet the particular needs of an individual, but an abundance of options may cause confusion and lead to selection errors. The aim of this project is to better understand why individuals often make poor choices when faced with complex decisions, and to suggest guidelines and selection interface designs that improve individuals' decision-making performance. Our experimental approach is to quantify the frequency and magnitude of selection errors when individuals are asked to choose the optimal plan from among a set of competing plans. This decision closely mimics the task of choosing among drug plans that include coverage for some drugs but not others, but also applies generally to other health plan selection choices. The proposed experiment interface will present each subject with a series of matrices each showing the attributes (analogous to the set of covered and not covered drugs) of each selection option (i.e., all available Part D drug plans). Experimental subjects will be asked to select the best plan from among the available options, and will be financially compensated in proportion to the accuracy of their selections. We will systematically examine how subjects' decisions are affected by the complexity of the problems they are facing. Also, variations in the experimental interface will test competing behavioral theories about how people process information and make complex choices, leading the development of a decision-making model against which improved formats can be tested. Central to the experimental design will be a careful investigation of decision-making acumen as a function of demographic factors including education level, sex, and especially age (preliminary work has demonstrated seniors under-perform substantially in complex settings). Subjects will be recruited via in-person visits to seniors' facilities and electronically from among a very large demographically-diverse on-line experimental economics subject pool. Differences among the subject pools and the effect of compensation amount on subject performance will be measured. Project outcomes will include recommendations to policy-makers on structuring complex choices to minimize selection errors. As a result, under-performing groups could be enabled to make better choices about health insurance and drug coverage, improving health outcomes of seniors. Project Narrative: The goal of this project is to further our understanding of the potential for error when people encounter complex decisions, as in the selection of health care and drug coverage plans. This study will examine underlying differences in decision-making acumen between the general population and more poorly performing sub-groups, possibly relating to education level, sex, and especially age. Study outcomes will include recommendations for restructuring decision sets to enable under-performing groups, especially seniors, to make better long-term choices improving their own health outcomes.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.socec.2013.08.007
发表时间:
2013-12-01
期刊:
JOURNAL OF SOCIO-ECONOMICS
影响因子:
--
作者:
[Deck, Cary, Kimbrough, Erik O.]
通讯作者:
Kimbrough, Erik O.
DOI:
10.1016/j.jebo.2011.07.016
发表时间:
2012
期刊:
Journal of economic behavior & organization
影响因子:
2.2
作者:
[Besedeš,Tibor, Deck,Cary, Sarangi,Sudipta, Shor,Mikhael]
通讯作者:
Shor,Mikhael
Confusion from Profusion: Decision Making with Many Options
-
批准号:7388683
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2008
-
负责人:Mikhael Shor
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: